{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:01:02Z","timestamp":1793109662410,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800130"],"award-info":[{"award-number":["81800130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560342"],"award-info":[{"award-number":["81560342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cca.2024.119680","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T06:11:58Z","timestamp":1713420718000},"page":"119680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Guideline for diagnosis and management of congenital dysfibrinogenemia"],"prefix":"10.1016","volume":"561","author":[{"given":"Jie","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faquan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.cca.2024.119680_b0005","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(13)70004-5","article-title":"Epidemiology and treatment of congenital fibrinogen deficiency","volume":"130","author":"Peyvandi","year":"2012","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.cca.2024.119680_b0010","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/j.1538-7836.2006.02094.x","article-title":"The molecular basis of quantitative fibrinogen disorders","volume":"4","author":"Asselta","year":"2006","journal-title":"J. Thrombos. Haemostas.: JTH"},{"issue":"2","key":"10.1016\/j.cca.2024.119680_b0015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bjh.12085","article-title":"Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia","volume":"160","author":"Shapiro","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.cca.2024.119680_b0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/iub.2437","article-title":"Reference intervals for routine biochemical markers and body mass index: a study based on healthcare center database in northeastern Iran","volume":"73","author":"Ghazizadeh","year":"2021","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.cca.2024.119680_b0025","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2006-08-040956","article-title":"Human plasma fibrinogen is synthesized in the liver","volume":"109","author":"Tennent","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cca.2024.119680_b0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1749-6632.2001.tb03535.x","article-title":"Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion","volume":"936","author":"Redman","year":"2001","journal-title":"Ann. New York Acad. Sci."},{"issue":"2","key":"10.1016\/j.cca.2024.119680_b0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2141.2001.02892.x","article-title":"The dysfibrinogenaemias","volume":"114","author":"Roberts","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2024.119680_b0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2001.tb03492.x","article-title":"Crystal structure studies on fibrinogen and fibrin","volume":"936","author":"Doolittle","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.cca.2024.119680_b0045","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1073\/pnas.77.3.1374","article-title":"Evidence for four different polymerization sites involved in human fibrin formation","volume":"77","author":"Olexa","year":"1980","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: an update","volume":"39","author":"de Moerloose","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"issue":"8","key":"10.1016\/j.cca.2024.119680_b0055","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J. Thrombos. Haemostas.: JTH"},{"issue":"12","key":"10.1016\/j.cca.2024.119680_b0060","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V82.12.3658.3658","article-title":"Fibrinogen Mitaka II: a hereditary dysfibrinogen with defective thrombin binding caused by an A alpha Glu-11 to Gly substitution","volume":"82","author":"Niwa","year":"1993","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cca.2024.119680_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2007.02.011","article-title":"Fibrinogen Nov\u00fd Jic\u00edn and Praha II: cases of hereditary Aalpha 16 Arg\u2013>Cys and Aalpha 16 Arg\u2013>His dysfibrinogenemia","volume":"121","author":"Kotl\u00edn","year":"2007","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.cca.2024.119680_b0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0049-3848(01)00318-8","article-title":"Three new cases of dysfibrinogenemia: Poissy III, Saint-Germain I and Tahiti","volume":"103","author":"Mathonnet","year":"2001","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.cca.2024.119680_b0075","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2516.2008.01795.x","article-title":"Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias","volume":"14","author":"Hill","year":"2008","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.cca.2024.119680_b0080","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2019.020503","volume":"29","author":"Broni\u0107","year":"2019","journal-title":"Biochem. Med."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/labmed\/lmx050","article-title":"Coagulation testing in the core laboratory","volume":"48","author":"Winter","year":"2017","journal-title":"Lab. Med."},{"issue":"3","key":"10.1016\/j.cca.2024.119680_b0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11239-018-1689-z","article-title":"Abnormal fibrinogen with an A\u03b1 16Arg \u2192 Cys substitution is associated with multiple cerebral infarctions","volume":"46","author":"Luo","year":"2018","journal-title":"J. Thromb. Thrombol."},{"issue":"39","key":"10.1016\/j.cca.2024.119680_b0095","doi-asserted-by":"crossref","first-page":"e4864","DOI":"10.1097\/MD.0000000000004864","article-title":"Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His","volume":"95","author":"Luo","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2024.119680_b0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cca.2015.06.002","article-title":"Dysfibrinogenemia in a patient undergoing artificial abortion after misdiagnosis and review of the literature","volume":"447","author":"Yan","year":"2015","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"issue":"3","key":"10.1016\/j.cca.2024.119680_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22319","article-title":"Management of dysfibrinogenemia in pregnancy: a case report","volume":"32","author":"Yan","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0110","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12185-016-2157-1","article-title":"A novel mutation in the fibrinogen A\u03b1 chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release","volume":"105","author":"Yan","year":"2017","journal-title":"Int. J. Hematol."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0115","doi-asserted-by":"crossref","first-page":"e22322","DOI":"10.1002\/jcla.22322","article-title":"Combined use of Clauss and prothrombin time-derived methods for determining fibrinogen concentrations: Screening for congenital dysfibrinogenemia","volume":"32","author":"Xiang","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.cca.2024.119680_b0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ijlh.13349","article-title":"Standardization of prothrombin time\/international normalized ratio (PT\/INR)","volume":"43","author":"Dorgalaleh","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"7","key":"10.1016\/j.cca.2024.119680_b0125","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4065\/82.7.864","article-title":"How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults","volume":"82","author":"Kamal","year":"2007","journal-title":"Mayo Clin. Proc."},{"issue":"Suppl 5","key":"10.1016\/j.cca.2024.119680_b0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2516.2010.02304.x","article-title":"Tests of global haemostasis and their applications in bleeding disorders","volume":"16","author":"Nair","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.cca.2024.119680_b0135","first-page":"59","article-title":"Optimizing the Verification of Mean Normal Prothrombin Time (MNPT) and International Sensitivity Index (ISI) for accurate conversion of Prothrombin Time (PT) to International Normalized Ratio (INR), Methods in molecular biology (Clifton","volume":"1646","author":"Favaloro","year":"2017","journal-title":"N.J.)"},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0140","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1365-2516.2008.01831.x","article-title":"Rare inherited disorders of fibrinogen","volume":"14","author":"Acharya","year":"2008","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0145","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bcmd.2015.06.002","article-title":"Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia","volume":"55","author":"Zhou","year":"2015","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.cca.2024.119680_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2020.102489","article-title":"Identification and characterization of novel mutations in Chinese patients with congenital fibrinogen disorders","volume":"86","author":"Zhou","year":"2021","journal-title":"Blood Cell Mol. Dis."},{"issue":"1\u20132","key":"10.1016\/j.cca.2024.119680_b0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0009-8981(02)00293-0","article-title":"Identification of a dysfibrinogenemia of gammaR275C (Fibrinogen Fukushima)","volume":"325","author":"Imafuku","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2024.119680_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2022.01.009","article-title":"Congenital dysfibrinogenemia in major surgery: a description of four cases and review of the literature","volume":"528","author":"Yan","year":"2022","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5858\/2002-126-0499-LDOD","article-title":"Laboratory diagnosis of dysfibrinogenemia","volume":"126","author":"Cunningham","year":"2002","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.cca.2024.119680_b0170","first-page":"181","article-title":"Fibrinogen, methods in molecular biology","volume":"992","author":"Stang","year":"2013","journal-title":"(Clifton N.J.)"},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0175","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/ijlh.12719","article-title":"Influences of argatroban on five fibrinogen assays","volume":"39","author":"Zhang","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"issue":"12","key":"10.1016\/j.cca.2024.119680_b0180","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1345\/aph.1R179","article-title":"Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study","volume":"46","author":"Dager","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.cca.2024.119680_b0185","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ALN.0b013e31817885b7","article-title":"Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin","volume":"109","author":"Molinaro","year":"2008","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0190","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0036-1579636","article-title":"How to assess fibrinogen levels and fibrin clot properties in clinical practice?","volume":"42","author":"Undas","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0195","article-title":"Use of fibrinogen determination methods in differential diagnosis of hypofibrinogenemia and dysfibrinogenemia","volume":"67","author":"Skornova","year":"2021","journal-title":"Clin. Lab."},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0200","first-page":"1337","article-title":"Comparison of fibrinogen concentrations determined by the Clauss method with prothrombin-derived measurements on an automated coagulometer","volume":"7","author":"Guven","year":"2022","journal-title":"J. Lab. Med."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0205","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1055\/a-1182-3510","article-title":"From routine to research laboratory: strategies for the diagnosis of congenital fibrinogen disorders","volume":"40","author":"Casini","year":"2020","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.cca.2024.119680_b0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.thromres.2019.03.002","article-title":"Whole-exome sequencing identified novel mutations in FGA and FGG genes in the patients with decreased fibrinogen","volume":"177","author":"Cao","year":"2019","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0215","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/j.thromres.2010.09.004","article-title":"Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia","volume":"126","author":"Miesbach","year":"2010","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.cca.2024.119680_b0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.thromres.2004.05.008","article-title":"Diagnostic utility of comparing fibrinogen Clauss and prothrombin time derived method","volume":"114","author":"Llamas","year":"2004","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0225","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0049-3848(94)90287-9","article-title":"Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio","volume":"76","author":"Krammer","year":"1994","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.cca.2024.119680_b0230","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/jth.14216","article-title":"Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH","volume":"16","author":"Casini","year":"2018","journal-title":"J. Thrombos. Haemostas.: JTH"},{"issue":"9","key":"10.1016\/j.cca.2024.119680_b0235","first-page":"602","article-title":"Diagnosis and management of dysfibrinogenemia","volume":"16","author":"Shapiro","year":"2018","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0240","first-page":"405","article-title":"Diagnosis of congenital fibrinogen disorders","volume":"74","author":"Lebreton","year":"2016","journal-title":"Ann. Biol. Clin."},{"issue":"2","key":"10.1016\/j.cca.2024.119680_b0245","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1538-7836.2005.01139.x","article-title":"Bbeta 14 Arg \u2013> Cys variant dysfibrinogen and its association with thrombosis","volume":"3","author":"Castaman","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0250","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.12916","article-title":"Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management","volume":"13","author":"Casini","year":"2015","journal-title":"J. Thrombos. Haemostas.: JTH"},{"issue":"8","key":"10.1016\/j.cca.2024.119680_b0255","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1055\/s-0041-1742170","article-title":"Mutations accounting for congenital fibrinogen disorders: an update","volume":"48","author":"Richard","year":"2022","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0260","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s12185-020-02842-9","article-title":"Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia","volume":"111","author":"Simurda","year":"2020","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.cca.2024.119680_b0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.thromres.2019.08.012","article-title":"Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: identification of three novel fibrinogen gamma chain mutations","volume":"182","author":"Wypasek","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cca.2024.119680_b0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2001.tb03495.x","article-title":"A database for human fibrinogen variants","volume":"936","author":"Hanss","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.cca.2024.119680_b0275","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.5858\/2002-126-1387-DAT","article-title":"Dysfibrinogenemia and thrombosis","volume":"126","author":"Hayes","year":"2002","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mbc.0000224841.48463.be","article-title":"Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group","volume":"17","author":"Santacroce","year":"2006","journal-title":"Blood Coagul. Fibrinol."},{"issue":"9","key":"10.1016\/j.cca.2024.119680_b0285","doi-asserted-by":"crossref","first-page":"e24624","DOI":"10.1002\/jcla.24624","article-title":"Misdiagnosis of a patient with congenital dysfibrinogenemia: a case report and literature review","volume":"36","author":"Chen","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.cca.2024.119680_b0290","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11239-019-01958-y","article-title":"Congenital fibrinogen disorders with repeated thrombosis","volume":"49","author":"Zhang","year":"2020","journal-title":"J. Thromb. Thrombol."},{"issue":"35","key":"10.1016\/j.cca.2024.119680_b0295","doi-asserted-by":"crossref","first-page":"12996","DOI":"10.12998\/wjcc.v10.i35.12996","article-title":"Congenital dysfibrinogenemia misdiagnosed and inappropriately treated as acute fatty liver in pregnancy: a case report and review of literature","volume":"10","author":"Jia","year":"2022","journal-title":"World J. Clin. Cases"},{"issue":"40","key":"10.1016\/j.cca.2024.119680_b0300","doi-asserted-by":"crossref","first-page":"e12697","DOI":"10.1097\/MD.0000000000012697","article-title":"A novel fibrinogen variant in a Chinese pedigree with congenital dysfibrinogenemia caused by FGA P. Arg38Thr mutation: a case report","volume":"97","author":"Cai","year":"2018","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0305","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/ijlh.12721","article-title":"Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories","volume":"39","author":"Jennings","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0310","first-page":"406","article-title":"Diagnosis of congenital dysfibrinogenemia","volume":"43","author":"Zhou","year":"2020","journal-title":"Chin. J. Lab. Med."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0320","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0036-1571339","article-title":"Clinical features and management of congenital fibrinogen deficiencies","volume":"42","author":"Casini","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.cca.2024.119680_b0325","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.cca.2024.119680_b0330","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1538-7836.2006.02014.x","article-title":"Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia","volume":"4","author":"Peyvandi","year":"2006","journal-title":"J. Thrombos. Haemostas.: JTH"},{"issue":"3","key":"10.1016\/j.cca.2024.119680_b0335","first-page":"247","article-title":"Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency","volume":"32","author":"Kreuz","year":"2005","journal-title":"Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis"},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0340","first-page":"968","article-title":"A Chinese family with congenital Dysfibrinogenemia carries a heterozygous missense mutation in FGA: Concerning the genetic abnormality and clinical treatment","volume":"33","author":"Zhou","year":"2017","journal-title":"Pakistan J. Med. Sci."},{"issue":"46","key":"10.1016\/j.cca.2024.119680_b0345","doi-asserted-by":"crossref","first-page":"e31644","DOI":"10.1097\/MD.0000000000031644","article-title":"A low-dose therapy of fibrinogen supplement during perioperative period of total knee arthroplasty in an asymptomatic man with congenital dysfibrinogenemia: a case report","volume":"101","author":"Meng","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2024.119680_b0350","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2022.07.005","article-title":"Congenital (hypo-)dysfibrinogenemia and bleeding: a systematic literature review","volume":"217","author":"Li","year":"2022","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.cca.2024.119680_b0355","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","article-title":"Natural history of patients with congenital dysfibrinogenemia","volume":"125","author":"Casini","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0360","article-title":"Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders","volume":"60","author":"Mohsenian","year":"2021","journal-title":"Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis"},{"issue":"Suppl 1","key":"10.1016\/j.cca.2024.119680_b0365","first-page":"239","article-title":"Dysfibrinogenemia with Subgaleal Hematoma: an Unusual Presentation, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood","volume":"32","author":"Khare","year":"2016","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.cca.2024.119680_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/01.3001.0014.0948","article-title":"Congenital dysfibrinogenemia as a rare cause of recurrent gastrointestinal bleeding","volume":"92","author":"Lebowa","year":"2020","journal-title":"Pol. Przegl. Chir."},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0375","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/hae.13061","article-title":"Management of congenital quantitative fibrinogen disorders: a Delphi consensus","volume":"22","author":"Casini","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.cca.2024.119680_b0380","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2147\/VHRM.S5305","article-title":"Treatment of congenital fibrinogen deficiency: overview and recent findings","volume":"5","author":"Tziomalos","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0385","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0029-1225758","article-title":"Congenital fibrinogen disorders","volume":"35","author":"de Moerloose","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"issue":"7","key":"10.1016\/j.cca.2024.119680_b0390","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1517\/14712598.8.7.979","article-title":"Treatment of congenital fibrinogen disorders","volume":"8","author":"de Moerloose","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"issue":"5","key":"10.1016\/j.cca.2024.119680_b0395","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2516.2004.00944.x","article-title":"The rare coagulation disorders\u2013review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"10","author":"Bolton-Maggs","year":"2004","journal-title":"Haemophilia"},{"issue":"9","key":"10.1016\/j.cca.2024.119680_b0400","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1538-7836.2011.04424.x","article-title":"Fibrinogen replacement therapy for congenital fibrinogen deficiency","volume":"9","author":"Bornikova","year":"2011","journal-title":"J. Thrombos. Haemostas.: JTH"},{"key":"10.1016\/j.cca.2024.119680_b0405","doi-asserted-by":"crossref","unstructured":"M. Nagler, J.A. Kremer Hovinga, L. Alberio, K. Peter-Salonen, H. von Tengg-Kobligk, D. Lottaz, M. Neerman-Arbez, B. L\u00e4mmle, Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review, Thromb. Haemos. 116(4) (2016) 722-32.","DOI":"10.1160\/TH16-02-0082"},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0410","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.hoc.2021.07.011","article-title":"Disorders of Fibrinogen and Fibrinolysis","volume":"35","author":"May","year":"2021","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.cca.2024.119680_b0415","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-0037-1613195","article-title":"Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I)","volume":"88","author":"de Bosch","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.cca.2024.119680_b0420","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.thromres.2011.03.012","article-title":"Successive bleeding and thrombotic complications in a patient with afibrinogenemia: a case report","volume":"128","author":"Chevalier","year":"2011","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.cca.2024.119680_b0425","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1046\/j.1538-7836.2003.00244.x","article-title":"Two novel fibrinogen variants found in patients with pulmonary embolism and their families","volume":"1","author":"Hanss","year":"2003","journal-title":"J. Thrombos. Haemostas.: JTH"},{"issue":"1","key":"10.1016\/j.cca.2024.119680_b0430","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1653741","article-title":"Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen","volume":"73","author":"Haverkate","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.cca.2024.119680_b0435","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.cca.2024.119680_b0440","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1182\/blood.V96.3.1191","article-title":"Familial thrombophilia associated with fibrinogen paris V: Dusart syndrome","volume":"96","author":"Tarumi","year":"2000","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cca.2024.119680_b0445","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V82.8.2462.2462","article-title":"Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure","volume":"82","author":"Collet","year":"1993","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cca.2024.119680_b0450","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2141.2006.06129.x","article-title":"The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance","volume":"134","author":"Flood","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.cca.2024.119680_b0455","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0039-1677840","article-title":"Laboratory diagnostics in thrombophilia","volume":"39","author":"Linnemann","year":"2019","journal-title":"Hamostaseologie"},{"issue":"10-s","key":"10.1016\/j.cca.2024.119680_b0460","first-page":"44","article-title":"Hereditary thrombophilia","volume":"90","author":"Dautaj","year":"2019","journal-title":"Acta Bio-Med.: Atenei Parmens."},{"key":"10.1016\/j.cca.2024.119680_b0465","unstructured":"[Chinese guidelines for diagnosis, prevention and treatment of thrombophilia (2021)], Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 42(11) (2021) 881\u2013888."},{"issue":"7","key":"10.1016\/j.cca.2024.119680_b0470","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2003-07-2316","article-title":"Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk)","volume":"103","author":"Lefebvre","year":"2004","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.cca.2024.119680_b0475","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.2020010116","article-title":"How I treat dysfibrinogenemia","volume":"138","author":"Casini","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cca.2024.119680_b0480","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1055\/s-0038-1673685","article-title":"Mutational epidemiology of congenital fibrinogen disorders","volume":"118","author":"Casini","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.cca.2024.119680_b0485","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2141.2000.01993.x","article-title":"Prenatal and peripartum management of congenital afibrinogenaemia","volume":"109","author":"Kobayashi","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.cca.2024.119680_b0490","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/hae.13825","article-title":"Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review","volume":"25","author":"Valiton","year":"2019","journal-title":"Haemophilia"},{"issue":"10","key":"10.1016\/j.cca.2024.119680_b0495","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1034\/j.1600-0412.2003.00211.x","article-title":"Dysfibrinogenemia during pregnancy treated successfully with fibrinogen","volume":"82","author":"Yamanaka","year":"2003","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.cca.2024.119680_b0500","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/a-1717-7663","article-title":"Thrombophilia, thrombosis and thromboprophylaxis in pregnancy: for what and in whom?","volume":"42","author":"Middeldorp","year":"2022","journal-title":"Hamostaseologie"},{"issue":"2 Suppl","key":"10.1016\/j.cca.2024.119680_b0505","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.cca.2024.119680_b0510","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/a-1132-0750","article-title":"Prevention of venous thromboembolism during pregnancy and the puerperium with a special focus on women with hereditary thrombophilia or prior VTE-position paper of the working group in women's health of the society of thrombosis and haemostasis (GTH)","volume":"40","author":"Hart","year":"2020","journal-title":"Hamostaseologie"},{"issue":"22","key":"10.1016\/j.cca.2024.119680_b0515","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.cca.2024.119680_b0520","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00001721-199302000-00011","article-title":"Unusual A alpha 16Arg\u2013>Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings","volume":"4","author":"Galanakis","year":"1993","journal-title":"Blood Coagul. Fibrinol."},{"issue":"4","key":"10.1016\/j.cca.2024.119680_b0525","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/rth2.12127","article-title":"Identification and characterization of novel mutations implicated in congenital fibrinogen disorders","volume":"2","author":"Smith","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124019211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124019211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T11:42:24Z","timestamp":1720957344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124019211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":104,"alternative-id":["S0009898124019211"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119680","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline for diagnosis and management of congenital dysfibrinogenemia","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119680"}}